106
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Three-Decade Successive Establishment of Care for Women/Girls from Families with Haemophilia

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 133-143 | Received 21 Jul 2022, Accepted 13 Sep 2022, Published online: 01 Oct 2022

References

  • van Galen KP, d’Oiron R, James P, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: communication from the SSC of the ISTH. J Thromb Haemost. 2021;19(8):1883–1887. doi:10.1111/jth.15397
  • Bellis EK, Li AD, Jayasinghe YL, et al. Exploring the unmet needs of parents of adolescent girls with heavy menstrual bleeding and dysmenorrhea: a qualitative study. J Pediatr Adolesc Gynecol. 2020;33:271–277. doi:10.1016/j.jpag.2019.12.007
  • Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AH, et al. Bleeding in carriers of hemophilia. Blood. 2006;108(1):52–56. doi:10.1182/blood-2005-09-3879
  • Paroskie A, Gailani D, DeBaun MR, Sidonio RF Jr. A cross-sectional study of bleeding phenotype in haemophilia A carriers. Br J Haematol. 2015;170(2):223–228. doi:10.1111/bjh.13423
  • Gilchrist GS, Hammond D, Melnyk J. Hemophilia A in a phenotypically normal female with XX-XO mosaicism. N Engl J Med. 1965;273(26):1402–1406. doi:10.1056/NEJM196512232732602
  • Chuansumrit A, Sasanakul W, Goodeve A, et al. Inversion of intron 22 of the factor VIII gene in a girl with severe hemophilia A and Turner’s syndrome. Thromb Haemost. 1999;82(4):1379. doi:10.1055/s-0037-1614406
  • Morita H, Kagami M, Ebata Y, Yoshimura H. The occurrence of homozygous hemophilia in a female. Acta Haematol. 1971;45(2):112–119. doi:10.1159/000208614
  • Piétu G, Thomas-Maison N, Sié P, Larrieu MJ, Meyer D. Haemophilia A in a female: study of a family using intragenic and extragenic restriction site polymorphisms. Thromb Haemost. 1988;60(1):102–106. doi:10.1055/s-0038-1647644
  • Windsor S, Lyng A, Taylor SA, Ewenstein BM, Neufeld EJ, Lillicrap D. Severe haemophilia A in a female resulting from two de novo factor VIII mutations. Br J Haematol. 1995;90(4):906–909. doi:10.1111/j.1365-2141.1995.tb05213.x
  • Mannucci PM, Coppola R, Lombardi R, Papa M, De Biasi R. Direct proof of extreme lyonization as a cause of low factor VIII levels in females. Thromb Haemost. 1978;39(2):544–545. doi:10.1055/s-0038-1646723
  • Favier R, Lavergne JM, Costa JM, et al. Unbalanced X-chromosome inactivation with a novel FVIII gene mutation resulting in severe hemophilia A in a female. Blood. 2000;96(13):4373–4375. doi:10.1182/blood.V96.13.4373
  • Bicocchi MP, Migeon BR, Pasino M, et al. Familial nonrandom inactivation linked to the X inactivation centre in heterozygotes manifesting haemophilia A. Eur J Hum Genet. 2005;13(5):635–640. doi:10.1038/sj.ejhg.5201386
  • Renault NK, Dyack S, Dobson MJ, Costa T, Lam WL, Greer WL. Heritable skewed X-chromosome inactivation leads to haemophilia A expression in heterozygous females. Eur J Hum Genet. 2007;15(6):628–637. doi:10.1038/sj.ejhg.5201799
  • Knobe KE, Sjörin E, Soller MJ, Liljebjörn H, Ljung RC. Female haemophilia A caused by skewed X inactivation. Haemophilia. 2008;14(4):846–848. doi:10.1111/j.1365-2516.2008.01754.x
  • Minks J, Robinson WP, Brown CJ. A skewed view of X chromosome inactivation. J Clin Invest. 2008;118(1):20–23. doi:10.1172/JCI34470
  • Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Subcommittee on Factor VIII, Factor IX and rare coagulation disorders of the scientific and standardization committee of the international society on thrombosis and hemostasis. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935–1939. doi:10.1111/jth.12672
  • Hardisty RM, Macpherson JC. A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath Haemorrh. 1962;7:215–228.
  • Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest. 1972;29(Suppl124):21–27.
  • Fishman DJ, Jones PK, Menitove JE, et al. Detection of the carrier state for classic hemophilia using an enzyme-linked immunosorbent assay (ELISA). Blood. 1982;59:1163–1168. doi:10.1182/blood.V59.6.1163.1163
  • Chuansumrit A, Pintadit P, Isarangkura P, Hathirat P, Phongcharoen S. Detection of hemophilia A carrier. Rama Med J. 1993;13(1):1–6.
  • Pintadit P, Chuansumrit A, Chotsupakarn S, et al. Carrier detection in hemophilia A by using the ratio of factor VIII clotting activity and von Willebrand factor antigen. Thai J Hematol Transfus Med. 1996;6(1):24–31.
  • Kunkel LM, Smith KD, Boyer SH, et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA. 1977;74:1245–1249. doi:10.1073/pnas.74.3.1245
  • Sasanakul W, Chuansumrit A, Kadegasem P, Hathirat P. A comparison of DNA extraction between conventional phenol-chloroform and in-house modified method. Rama Med J. 1997;20:119–124.
  • Sasanakul W, Chuansumrit A, Rurgkhum S, Udomsubpayakul U, Hathirat P. DNA extraction and amplification of 10-day, room-temperature blood samples. J Med Assoc Thai. 1999;82(Suppl 1):S186–189.
  • Kadegasem P, Rurgkhum S, Sasanakul W, Chuansumrit A. DNA extraction from buffy coat sent by mail without ice. Thai J Hematol Transfus Med. 2001;11:167–171.
  • Peake I, Lilicrap DP, Boulyjenkov V, et al. Report of a joint WHO/WFH meeting on the control of haemophilia: carrier detection and prenatal diagnosis. Blood Coagul Fibrinolysis. 1993;4:313–344. doi:10.1097/00001721-199304000-00013
  • Rossetti LC, Radic CP, Larripa IB, De Brasi CD. Developing a new generation of tests for genotyping hemophilia-causative rearrangements involving int22h and int1h hotspots in the factor VIII gene. J Thromb Haemost. 2008;6:830–836. doi:10.1111/j.1538-7836.2008.02926.x
  • Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 1977;74(12):5463–5467. doi:10.1073/pnas.74.12.5463
  • Ganguly A, Rock MJ, Prockop DI. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragment: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA. 1993;90:10325–10329. doi:10.1073/pnas.90.21.10325
  • Williams IJH, Abuzenadah A, Winship PR, et al. Precise carrier diagnosis in families with hemophilia A: use of conformation sensitive gel electrophoresis for mutation screening and polymorphism analysis. Thromb Haemost. 1998;79:723–726. doi:10.1055/s-0037-1615052
  • Hink JL, Winship PR, Makris M, et al. A rapid method for haemophilia B mutation detection using conformation sensitive gel electrophoresis. Br J Haematol. 1999;104:915–918. doi:10.1046/j.1365-2141.1999.01274.x
  • Chuansumrit A, Sasanakul W, Promsonthi P, et al. Prenatal diagnosis for haemophilia: the Thai experience. Haemophilia. 2016;22:880–885. doi:10.1111/hae.13002
  • Betke K, Sanguansermsri T. Cytological differentiation of blood pigments, possibilities, results and practical application. Munch Med Wochenschr. 1972;114:1099–1104.
  • Baily DMD, Affara NA, Ferguson-Smith MA. The X-Y homologous gene amelogenin maps to the short arms of both the X and Y chromosome and is highly conserved in primates. Genomics. 1992;14:14203–14205.
  • Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992;51(6):1229.
  • Chuansumrit A, Panthangkura W, Isarangkura P, Hathirat P, Mahaphan W. Genetic counseling for hemophilia carriers. Thai J Hematol Transfus Med. 1993;3(1):37–50.
  • Orstavik KH, Scheibel E, Ingerslev J, Schwartz M. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B. Thromb Haemost. 2000;83(3):433–443. doi:10.1055/s-0037-1613833
  • Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063–2065. doi:10.1111/j.1538-7836.2010.03975.x
  • James PD, Mahlangu J, Bidlingmaier C, et al. Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study. Haemophilia. 2016;22(6):912–918. doi:10.1111/hae.13089
  • Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia. Haemophilia. 2020;26(Suppl6):1–158. doi:10.1111/hae.14046
  • Sooksriwong C, Boonkerd L, Chanjaruporn F, Chuansumrit A. Incremental cost effectiveness analysis for haemophilia home-based care programme in Thailand. Haemophilia. 2012;18(4):548. doi:10.1111/j.1365-2516.2012.02871.x
  • Pattanaprateep O, Chuansumrit A, Kongsakon R. Cost-utility analysis of home-based care for treatment of Thai hemophilia A and B. Value Health Reg Issues. 2014;3:73–78. doi:10.1016/j.vhri.2014.02.008
  • Goodeve AC, Chuansumrit A, Sasanakul W, et al. A comparison of the allelic frequencies of ten DNA polymorphisms associated with factor VIII and factor IX genes in Thai and Western European populations. Blood Coagul Fibrinolysis. 1994;5(1):29–35. doi:10.1097/00001721-199402000-00005
  • Loomans JI, Kruip MJ, Carcao M, et al. Desmopressin in moderate hemophilia A patients: a treatment with considering. Haematologica. 2018;103(3):550–557. doi:10.3324/haematol.2017.180059